Abstract: The invention provides novel monoclonal antibodies and the hybridomas that secrete them. The antibodies can be used for the diagnosis of a number of cancers, such as ovarian, esophageal and cervical carcinomas. A preferred antibody is secreted by a hybridoma deposited with the ATCC and has Accession No. HB 10570.
Type:
Grant
Filed:
November 16, 1992
Date of Patent:
June 14, 1994
Assignee:
The United States of America as represented by the Department of Health and Human Services
Inventors:
Mark C. Willingham, Kai Chang, Ira Pastan